CVS Health (NYSE:CVS) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft

Posted in :


CVS Health Co.  logosDeutsche Bank Aktiengesellschaft initiated coverage on shares of CVS Health (NYSE:CVS – Get Rating) in a report released on Monday morning, The Fly reports. The firm issued a hold rating on the pharmacy operator’s stock.

Several other research firms also recently issued reports on CVS. Morgan Stanley upped their price objective on CVS Health from $119.00 to $120.00 and gave the company an overweight rating in a research note on Friday, January 13th. Raymond James lowered their price target on shares of CVS Health from $115.00 to $110.00 and set an outperform rating on the stock in a report on Thursday, February 9th. Jefferies Financial Group increased their target price on CVS Health from $130.00 to $143.00 and gave the stock a buy rating in a research report on Thursday, February 9th. initiated coverage on shares of CVS Health in a report on Thursday, March 16th. They set a buy rating on the stock. Finally, Royal Bank of Canada reaffirmed an outperform rating and issued a $115.00 target price on shares of CVS Health in a research note on Thursday, February 9th. Three equity research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of Moderate Buy and an average target price of $118.24.

CVS Health Stock Performance

CVS opened at $76.04 on Monday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.67 and a current ratio of 0.94. The business’s 50-day simple moving average is $81.15 and its 200-day simple moving average is $90.06. The firm has a market capitalization of $97.64 billion, a PE ratio of 24.37, a PEG ratio of 1.20 and a beta of 0.61. CVS Health has a 52-week low of $72.11 and a 52-week high of $107.73.

Want More Great Investment Ideas?

CVS Health (NYSE:CVS – Get Rating) last released its quarterly earnings data on Wednesday, February 8th. The pharmacy operator reported $1.99 EPS for the quarter, beating the consensus estimate of $1.92 by $0.07. The company had revenue of $83.85 billion during the quarter, compared to the consensus estimate of $76.37 billion. CVS Health had a return on equity of 15.75% and a net margin of 1.29%. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.98 EPS. As a group, sell-side analysts expect that CVS Health will post 8.83 earnings per share for the current fiscal year.

CVS Health Announces Dividends

The firm also recently declared a quarterly dividend, which will be paid on Monday, May 1st. Shareholders of record on Friday, April 21st will be paid a $0.605 dividend. The ex-dividend date is Thursday, April 20th. This represents a $2.42 dividend on an annualized basis and a yield of 3.18%. CVS Health’s payout ratio is presently 77.56%.

Institutional Investors Weigh In On CVS Health

Several institutional investors and hedge funds have recently modified their holdings of CVS. Live Oak Investment Partners purchased a new position in shares of CVS Health in the 4th quarter worth $25,000. SRS Capital Advisors Inc. boosted its holdings in shares of CVS Health by 105.8% in the 3rd quarter. SRS Capital Advisors Inc. now owns 284 shares of the pharmacy operator’s stock worth $27,000 after purchasing an additional 146 shares during the period. VitalStone Financial LLC bought a new position in shares of CVS Health during the 4th quarter valued at approximately $28,000. Godsey & Gibb Inc. purchased a new stake in CVS Health during the 4th quarter valued at $28,000. Finally, Karp Capital Management Corp purchased a new position in CVS Health during the third quarter worth $30,000. Institutional investors own 77.29% of the company’s stock.

About CVS Health

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.

Featured Articles

The Fly logo

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CVS Health and related companies with’s FREE daily email newsletter.